戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 a treatment algorithm for SUNCT and SUNA for clinical practice.
2 the enzyme activity at the high dose used in clinical practice.
3 y compromises all aminoglycosides in current clinical practice.
4 an be collected in depression registries and clinical practice.
5 ent evidence for its implementation in daily clinical practice.
6 e of less than 5 min is safe and feasible in clinical practice.
7 ation, with excellent safety and efficacy in clinical practice.
8 ction is challenging to determine in routine clinical practice.
9 increasingly translated and implemented into clinical practice.
10 ination of information useful for concurrent clinical practice.
11 argeted axillary dissection (TAD) in routine clinical practice.
12 he IBD-DI in order to generalize its use for clinical practice.
13  profiles and the association of PIEZO1 with clinical practice.
14 years, CRC has remained a major challenge in clinical practice.
15 tudies are needed to validate this method in clinical practice.
16 ibility of its implementation within routine clinical practice.
17 en considering the place of trimetazidine in clinical practice.
18 normalities are not suspected during routine clinical practice.
19 ta exist to guide its optimal application to clinical practice.
20  questions about generalisability to routine clinical practice.
21  implementation of these assays into routine clinical practice.
22 second degree burns, which is challenging in clinical practice.
23 propriate for use in depression research and clinical practice.
24 ntervention, as well as the implications for clinical practice.
25 ecular subtypes of bladder cancer in routine clinical practice.
26 atic castration-resistant prostate cancer in clinical practice.
27 tion, and deployment of AI technologies into clinical practice.
28 veness and impact of model implementation in clinical practice.
29 ng methods potentially applicable in routine clinical practice.
30 f the ankle and foot commonly encountered in clinical practice.
31 nd limited VA improvements, in United States clinical practice.
32 evaluated to determine its potential role in clinical practice.
33 utions to mental health-related research and clinical practice.
34 ells, have impeded their transition into the clinical practice.
35 the implementation of this novel approach in clinical practice.
36 nsolidations visualized by micro-CT alike in clinical practice.
37 proach to classification of seizure types in clinical practice.
38 pproach to genetic evaluation and testing in clinical practice.
39 reliable and generalizable models for future clinical practice.
40 atients with R/M cSCC, supporting its use in clinical practice.
41 o anti-VEGF treatment administered in normal clinical practice.
42  trials and following individual patients in clinical practice.
43 implant for DME-related visual impairment in clinical practice.
44  the limits of who might benefit from CAC in clinical practice.
45 dity attracts less attention in research and clinical practice.
46 as unlikely and the results generalisable to clinical practice.
47 , the IBD Disk has not been validated yet in clinical practice.
48 the monitoring of anti-fibrotic therapies in clinical practice.
49 es for research into mechanisms but also for clinical practice.
50  information of 2 patients identified during clinical practice.
51 jectivity, consistency and accuracy in daily clinical practice.
52 of acute coronary syndrome is a challenge in clinical practice.
53 ed with intravascular microaxial LVAD use in clinical practice.
54 onse but have yet to be adopted routinely in clinical practice.
55 ns at an accuracy suitable for deployment in clinical practice.
56 e its importance, NASH is underrecognized in clinical practice.
57 ions and could eventually be translated into clinical practice.
58  produce findings that have implications for clinical practice.
59 ively streamline interpretability methods in clinical practice.
60 to the diverse circumstances seen in routine clinical practice.
61  DEX implant in this population during usual clinical practice.
62 gnificant amount of time if implemented into clinical practice.
63 urrent purely qualitative evaluation used in clinical practice.
64 ntroduction of such automatic methods in the clinical practice.
65 iomarkers with considerable implications for clinical practice.
66 l phenotypic assays are unevenly deployed in clinical practice.
67  if "gaming" might be used as a treatment in clinical practice.
68 have devices been suitable for transition to clinical practice.
69 elated to anti-VEGF therapy given in routine clinical practice.
70 ively validate and implement these models in clinical practice.
71 velopment and is poised to make an impact on clinical practice.
72 s to improve human-computer collaboration in clinical practice.
73  is coming for translation of this work into clinical practice.
74 e costly which limits their translation into clinical practice.
75 inicians in establishing target pressures in clinical practice.
76 discovery science through clinical trials to clinical practice.
77 nges the implementation of this biomarker in clinical practice.
78 plementary risk communication tool for AF in clinical practice.
79 eal CO2 removal, are increasingly applied in clinical practice.
80 ' willingness to adopt the 60-s/bp images in clinical practice.
81 of genome editing in both basic research and clinical practice.
82 future routine use of this promising tool in clinical practice.
83 cessfully bridging neuroscience discovery to clinical practice.
84  survival; however, it is often underused in clinical practice.
85 e age range of 8 to 17 years in research and clinical practice.
86 y to apply, and is, therefore, suggested for clinical practice.
87 , ranibizumab, or aflibercept during routine clinical practice.
88 edictive ability of tPSA (AUC 0.71), used in clinical practice.
89 er than previously reported when employed in clinical practice.
90 ights and guidance to intensivists for safer clinical practice.
91 t variability of SD-OCT and is often used in clinical practice.
92 help inform the use of the 4CMenB vaccine in clinical practice.
93 many questions remain regarding their use in clinical practice.
94 edural factors, poses a recurring dilemma in clinical practice.
95 n their male colleagues in the first year of clinical practice.
96 use they are frequently encountered in daily clinical practice.
97  consider it as an important 'vital sign' in clinical practice.
98 eir potential impact on drug development and clinical practices.
99 vide insightful assessments for research and clinical practices.
100 The effects of treatment advances on routine clinical practice across continental territories has not
101                   Patients undergoing FMT in clinical practices across North America were eligible.
102                                        Three clinical practice algorithms are also included.
103 optimally integrate Xpert and LAM tests into clinical practice algorithms remain unclear.
104                                           In clinical practice, an abnormal electrocardiogram with no
105 al stage, which would be of great benefit in clinical practice and a large cost-saving in clinical tr
106 idered for guidance of bone biopsies in both clinical practice and clinical trials.
107  extensively used as an anti-caries agent in clinical practice and daily life.
108 cancer patients, in order to ease its use in clinical practice and future research.
109 oduce meaningful data to inform decisions in clinical practice and health policy.
110 ements and monitoring for depression both in clinical practice and in research settings.
111  most common sustained cardiac arrhythmia in clinical practice and is known to be associated with sig
112 bility of results, and how it can be used in clinical practice and population health.
113 iers to implementing program components into clinical practice and presents implementation strategies
114 n this cohort potentially enables its use in clinical practice and provides the foundation for future
115  foregut and midgut, are often overlooked in clinical practice and radiological literature.
116 ists to adopt a developmental perspective in clinical practice and research by considering age-at-ons
117                                     However, clinical practice and research, especially in an era of
118 ting for ABI values of all 4 leg arteries in clinical practice and research.
119  across the age range of 8 up to 18 years in clinical practice and research.
120 vity afforded to neuropsychological tests in clinical practice and research.
121 ly established to determine the current best clinical practice and set up an international collaborat
122 affect patient adherence in order to improve clinical practice and support patient involvement in pre
123 ize the use of olodaterol and indacaterol in clinical practice and to quantify the off-label use in a
124                                  Structuring clinical practice and training around single conditions
125 o the profiling of drug resistance to inform clinical practice and treatment decision making.
126 ple scoring make the AECT ideally suited for clinical practice and trials.
127 fic equations include variables available in clinical practice and were generally more accurate than
128 t have changed but significant variations in clinical practices and outcomes between centres remain u
129 equation, as is creating connections between clinical practices and research programs.
130 nt challenges in the use of liquid biopsy in clinical practice, and consider ways the pathologist sho
131 g methods, considerations for translation to clinical practice, and considerations and caveats in the
132 isease are increasingly observed together in clinical practice, and development of nonalcoholic steat
133 rk for the translation of such findings into clinical practice, and evidence-based policies in order
134 s of AS by CMR is not routinely performed in clinical practice, and its role in evaluating and quanti
135 ates, and center-level variation in testing, clinical practice, and policies, we conducted a national
136 oreseeHome device in the current analysis of clinical practice application was limited.
137                            Embolic agents in clinical practice are limited by recanalization, risk of
138         Although poor outcomes reported from clinical practice are multifactorial, availability of re
139 need to be overcome to move PVs forward into clinical practice as an effective therapeutic option for
140                                   In routine clinical practice as in clinical trials, PA pressure-gui
141 consistently seen in clinical studies and in clinical practice as operators appropriately forgo ablat
142 workforce to deliver of high-quality care in clinical practice as we prepare for advanced therapeutic
143 trial findings will be replicated in routine clinical practice at scale.
144                            We aimed to audit clinical practices before and after introduction of a na
145  321) starting anti-VEGF for nAMD in routine clinical practice between January 1, 2006, and December
146  broad applications within basic science and clinical practice beyond DBS, offering a wealth of infor
147 y facilitate physicians treating patients in clinical practice but also provide the basis for future
148 ring in ulcerative colitis (UC) is useful in clinical practice but done infrequently.
149                 FCD is likely very common in clinical practice but may be under-diagnosed.
150          Prediction is primarily relevant to clinical practice, but is also used in research, and adm
151   The gaps between these recommendations and clinical practice by region have not been quantified.
152 he genetics of PPGL has been translated into clinical practice by the provision of widespread testing
153 o complement with potential applicability to clinical practice, (c) complement in disease across vari
154  trial before firm recommendations regarding clinical practice can be made.
155 ing in cardiac arrest prevention followed by clinical practice change whereby patients with high-risk
156                                   As part of clinical practice, chest CT scans were obtained for prim
157 ber 2019, our institution's echocardiography clinical practice committee approved use of EMW for pati
158 y disease continues to be debated in routine clinical practice, despite more than 2 decades of random
159 rs in FFPE samples to meet the need of daily clinical practice, especially for local laboratories or
160 idely utilized to manage challenges faced in clinical practice for early diagnosis and treatment of s
161 on that can be applied to current trials and clinical practice for high-grade gliomas.
162                           Registry data from clinical practice found residual visual acuity impairmen
163  commonly being used as adherence markers in clinical practice, further work is required to assess th
164                             Implications for clinical practice, gaps in knowledge, and future directi
165 y of Allergy and Clinical Immunology (EAACI) clinical practice guideline "systemic treatment of atopi
166                 Our purpose was to develop a clinical practice guideline (CPG) for systemic antibacte
167 The process begins with approval from ASCO's Clinical Practice Guideline Committee (CPGC) leadership
168 wing the Institute of Medicine procedure for clinical practice guideline development, a PubMed, EMBAS
169 rtment of Defense (DoD) approved a new joint clinical practice guideline for assessing and managing p
170 fense (DoD) released a joint update of their clinical practice guideline for managing dyslipidemia to
171                               We developed a clinical practice guideline for systemic antifungal prop
172   In 2017, the Endocrine Society updated its clinical practice guideline for the care of transgender
173 Department of Defense (DoD) approved a joint clinical practice guideline for the diagnosis and manage
174      The 2018 American Society of Hematology clinical practice guideline on prophylaxis for hospitali
175 e summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and
176 e summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and
177 ergy and Clinical Immunology has developed a clinical practice guideline to provide evidence-based re
178  patient-mediated interventions (2 studies), clinical practice guidelines (1 study), educational meet
179  the potential to improve the application of clinical practice guidelines and shared decision making
180                         Given there are many clinical practice guidelines available on the prevention
181                                              Clinical practice guidelines can benefit patients by red
182 t variation in the methodological quality of clinical practice guidelines for early mobilization, the
183    In this Policy Review, we present updated clinical practice guidelines for HDGC from the Internati
184                                       Future clinical practice guidelines in this area should focus o
185                                      Current clinical practice guidelines recommend a "wait-and-watch
186 althcare Epidemiology of America (IDSA-SHEA) clinical practice guidelines recommend excluding patient
187                                              Clinical practice guidelines recommend routine kidney fu
188                                      Various clinical practice guidelines support fluid removal using
189 a policy and set of procedures for endorsing clinical practice guidelines that have been developed by
190                                              Clinical practice guidelines were then ranked in tertile
191        This review aimed to identify current clinical practice guidelines worldwide, appraise their m
192 ardiac rehabilitation (CR) is recommended in clinical practice guidelines, but dose prescribed varies
193                   eGFR is now recommended by clinical practice guidelines, regulatory agencies and pu
194 e pulmonary disease (COPD) by all major COPD clinical practice guidelines.
195 stitute of Medicine's tenets for trustworthy clinical practice guidelines.
196  tactical approach of implementing published clinical practice guidelines/algorithms for early behavi
197  associated with LVEF improvement in routine clinical practice have not been clearly defined.
198 ase caused by several drugs commonly used in clinical practice, herbs and dietary supplements prescri
199            This study took place in a single clinical practice in an academic setting.
200 otential complementary application of HMI in clinical practice in conjunction with the B-mode to clas
201 d safety of IVT-AFL in patients with nAMD in clinical practice in France.
202 redictive algorithms will change the face of clinical practice in hepatology and transplantation.
203 ction methods and use as biomarkers in daily clinical practice in neurology is needed.
204 nalyze observational data at scale to inform clinical practice in real-time.
205                            These data inform clinical practice in settings where TB and HIV are endem
206 option of some of these methods into routine clinical practice in some centers.
207 ored when ATM inhibitors become available in clinical practice in the future.
208 lication of brain and spinal cord atrophy in clinical practice in the management of MS, considering t
209 an use, more radiopharmaceuticals will enter clinical practice in the next 5 years, potentially intro
210 SLIT was largely used in clinical trials and clinical practice in this last 30 years.
211 GNIFICANCE STATEMENT With recent advances in clinical practice including mechanical thrombectomy up t
212                   Seven ICIs are now used in clinical practice, including nivolumab and pembrolizumab
213 s in which ctDNA has the potential to change clinical practice, including the detection of minimal re
214                                Evaluation of clinical practices, including medical management recomme
215 r findings have significant implications for clinical practice, indicating that BG levels should be n
216 ver particularly long time periods to inform clinical practice is presently incomplete.
217  most randomized trials, but the benefit for clinical practice is unclear.
218      Implementation of these observations in clinical practice may improve our understanding as well
219                     Patient characteristics, clinical practices, mortality, and morbidity were studie
220 el laboratory tools might be translated into clinical practice, noting that they perform best when in
221 nsufficient to provide evidence for changing clinical practice of common eye diseases.
222             This article reviews the current clinical practice of MRI evaluation and interpretation o
223 nhance the reliability of the application to clinical practice of the TLICS classification, we retros
224 lergen Immunotherapy (AIT) was introduced in clinical practice on an empirical basis more than 100 ye
225 es the regulatory landscape, applications to clinical practice, opportunities for virtual clinical tr
226 idespread adoption or significantly affected clinical practice or outcomes.
227 need to better understand the performance in clinical practice outside of the research trial setting
228 al of patients with ENKTL treated in routine clinical practice over the past decade, likely to be att
229        HCC surveillance remains underused in clinical practice, particularly among patients with alco
230 r STI screening during PrEP care and current clinical practice, particularly for rectal and pharyngea
231 ent single-vessel FFR measurement in routine clinical practice, performing PCI, compared with not per
232 ese and other recent molecular advances into clinical practice proves difficult.
233                                           In clinical practice, providers need to decide which genes
234 e is significant variability in both law and clinical practice.Purpose and Objectives: This multisoci
235 th specific biomarkers traditionally used in clinical practice (r up to 0.73), and outperformed them
236 collaboration among providers to ensure that clinical practice reflects evidence-based recommendation
237                                              Clinical practices related to respiratory support have c
238 terial assays from basic research to routine clinical practice represents an exciting advance in resp
239 n England with community-onset UTI using the Clinical Practice Research Datalink (2007-2015) linked t
240 Britain (England, Wales, and Scotland) using Clinical Practice Research Datalink (CPRD) from 2004/200
241  case-control study using the United Kingdom Clinical Practice Research Datalink (CPRD) linked to hos
242 ted Kingdom primary healthcare database, the Clinical Practice Research Datalink (CPRD), linked with
243  a matched cohort study set in primary care (Clinical Practice Research Datalink GOLD 1998-2016) and
244 ort study using data from the United Kingdom Clinical Practice Research Datalink linked to the Hospit
245 a population-based cohort study using the UK Clinical Practice Research Datalink linked to the Hospit
246 , using newly available uptake data from the Clinical Practice Research Datalink pregnancy register,
247      An observational cohort study using the Clinical Practice Research Datalink was conducted using
248 mary care electronic health records from the Clinical Practice Research Datalink was performed.
249       We studied women in the United Kingdom Clinical Practice Research Datalink with a CA125 test pe
250  data from English practices from CPRD GOLD (Clinical Practice Research Datalink) and the SCI-Diabete
251                          Using data from the Clinical Practice Research Datalink, a large primary-car
252                                 Using the UK Clinical Practice Research Datalink, we formed a cohort
253  706 general practices in the United Kingdom Clinical Practice Research Datalink, with 66.2 million p
254 We analyzed UK primary care records from the Clinical Practice Research Datalink.
255 portant implications for future research and clinical practice resulting from the dynamic interaction
256 ective integration into drug development and clinical practice, robust assays with consistent results
257 ncorporation of MNA as a vital sign in daily clinical practice, self-reporting using validated questi
258 oronary artery disease (CAD) in a real-world clinical practice setting.
259 dditional studies should evaluate FujiLAM in clinical practice settings.
260 e specimen was obtained and the test result; clinical practice site sources; geolocation of patient r
261 eatment can work in conjunction with current clinical practices such as therapeutic hypothermia and p
262  and therefore their suitability for AIT and clinical practice support.
263  that treatment effects are weaker in actual clinical practice than in controlled studies, dissipate
264 pproach may benefit many biology studies and clinical practice that needs efficient delivery of exoge
265 study were to develop and test in real-world clinical practice the effectiveness of a comprehensive p
266 aptability to the requirements of real-world clinical practice, the latest versions of European and A
267      Despite being frequently encountered in clinical practice, the population-based incidence and tr
268       Even as PRSs are being introduced into clinical practice, there is a push to combine them with
269                              When applied to clinical practice, this could potentially allow practici
270 ores (PRSs) are poised to be translated into clinical practice through prediction of inborn health ri
271 on, and it can be efficiently implemented in clinical practice to assist neuro-oncologists or radiolo
272 d be further validated, and could be used in clinical practice to identify patients who require incre
273  myocardial deformation imaging into routine clinical practice to identify subclinical cardiovascular
274            This biomarker can be adapted for clinical practice to improve cancer treatment and care.
275                          Translation of this clinical practice to personal health and wellness tracki
276            CNNs could potentially be used in clinical practice to provide rapid and accurate 3D MRI g
277 urrent and future strategies in research and clinical practice to the benefits of sleep and depressio
278                          The purpose of this Clinical Practice Update is to provide practical and evi
279 troenterological Association (AGA) Institute Clinical Practice Update is to review the available evid
280 p, and underwent internal peer review by the Clinical Practice Updates Committee and external peer re
281 p, and underwent internal peer review by the Clinical Practice Updates Committee and external peer re
282 mmissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governin
283 mmissioned and approved by the AGA Institute Clinical Practice Updates Committee and the AGA Governin
284 optimization of these devices, as well as in clinical practice, vascular sections are idealized, poss
285 th mannitol, a first-line edema treatment in clinical practice, was also associated with increased su
286             Since DS slides are not standard clinical practice, we also integrated a cycle generative
287 nslate these methods to routine research and clinical practice, we developed a sequence-resolved benc
288 Through the addition of this new approach to clinical practice, we propose that oncologists might fin
289  and thereafter were followed up in ordinary clinical practice were collected until the end of 2017.
290 cribers' and patient group directions users' clinical practice were comparable (maximum score 46: nur
291  Overall, complication rates seen in routine clinical practice were low compared with clinical trial
292 rial findings can be safely implemented into clinical practice when patients on oral antibiotics are
293 rome, while greater use of this diagnosis in clinical practice will facilitate personalized intervent
294 gression and response to therapy into future clinical practice will likely improve the treatment of t
295 e retrospectively identified 153 adults in a clinical practice with cyclodeviation assessed using dou
296 at are relevant to radiologists in a routine clinical practice with MRI correlation.
297 ety of PA pressure-guided therapy in routine clinical practice with special focus on subgroups define
298  Lens (RxSight) was recently introduced into clinical practice, with the first results being very enc
299 ve rehabilitation and exercise training into clinical practice within the next decade.
300                       This review presents a clinical practice workflow that has been successful sinc

 
Page Top